Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma

Nat Commun. 2023 Sep 26;14(1):5992. doi: 10.1038/s41467-023-41611-0.

BriTROC Investigators:
R M Glasspool, C Gourley, R Kennedy, G Hall, R Edmondson, A Clamp, S Sundar, A Walter, M Hall, H Gabra, C Fotopoulou, E Brockbank, A Montes, M Lockley

¹ CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.
² Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK.
³ Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
⁴ CRUK Glasgow Clinical Trials Unit, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
⁵ Department of Histopathology, Queen Elizabeth University Hospital, Glasgow, UK.
⁶ Centro Nacional de Investigaciones Oncológicas, Madrid, Spain.
⁷ CRUK Cambridge Institute, University of Cambridge, Cambridge, UK. james.brenton@cruk.cam.ac.uk.
⁸ Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. james.brenton@cruk.cam.ac.uk.
⁹ Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK. i.mcneish@imperial.ac.uk.

^# Contributed equally.

No abstract available

Publication types